Latex Agglutination Test Kits Market
Latex Agglutination Test Kits Market Forecasts to 2028 - Global Analysis By Test Type (Antibody Detection, Antigen Testing and Other Test Types), By Sample Type (Urine, Blood, Cerebrospinal Fluid (Lumber Puncture), Sperm and Other Sample Types), By Indication, By Product, By Application, By End User and By Geography
|
Years Covered |
2020-2028 |
|
Estimated Year Value (2022) |
US $475.4 MN |
|
Projected Year Value (2028) |
US $685.9 MN |
|
CAGR (2022 - 2028) |
6.3% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Latex Agglutination Test Kits Market is accounted for $475.4 million in 2022 and is expected to reach $685.9 million by 2028 growing at a CAGR of 6.3% during the forecast period. The identification of antibodies or antigens in body fluids such as cerebrospinal fluid (CSF), blood, urine, and saliva is usually done using latex agglutination test kits. The test kits include coating either an antigen or an antibody on a latex bead-based artificial carrier particle. The increasing prevalence of autoimmune and infectious disorders as well as the wide range of applications for these kits help to drive adoption of the product.
According to the National Institutes of Health (NIH) in 2021, the global incidence of meningitis is estimated to be 20.0 cases per 100,000 people, representing about 1.2 million cases.
Market Dynamics:
Driver:
Diverse application areas of latex agglutination test kits
Hepatitis, meningitis, rheumatoid arthritis, tonsillitis, and other streptococcal diseases are frequently diagnosed with latex agglutination test kits. The use of these kits to diagnose a variety of viral and autoimmune diseases leads to a bright future for this sector. The Wellcogen Strep B Rapid Latex Agglutination Test, the Wellcogen Strep B 30 Pk for Staphylococcus, the Waaler Rose Latex Kits for rheumatoid arthritis, the E. coli O157 Latex Test for E. coli, and the ASI Rubella test for Rubella Virus are a few instances of commercially accessible products.
Restraint:
Emergence of new and reliable alternate diagnostics
Despite the fact that latex agglutination test kits have a number of benefits for diagnostic care, the development of innovative and trustworthy alternative diagnostics, particularly in high-growing markets like the United States and Europe, has significantly hampered market growth. These test kits are very rapid, simple, and affordable. Standardization is also required to prevent artificially positive results. The market is anticipated to have limited growth possibilities due to the limitations of these kits and higher technological advancements in infectious diseases diagnostics.
Opportunity:
Rising prevalence of infectious and autoimmune diseases
For common infectious diseases such as meningitis, pneumonia, hepatitis, Haemophilus influenzae, typhoid, and tuberculosis, latex agglutination kits are provided. Since these test kits offer quick diagnosis, the increasing prevalence of certain infectious diseases will drive demand for products. Additionally, the rise in autoimmune disorders like lupus and rheumatoid arthritis cases, as well as the accessibility of these kits in developing countries, encourage the rapid uptake of the products.
Threat:
Human error in interpretation of results
Because immunoagglutination assays do not have an endpoint, reaction time analysis must be taken into consideration while designing an experiment. Also, as the reaction time increases, the liquid dries and the particles settle, making it more difficult to read the results and increasing the likelihood of false-positive interpretations. This assay can only be classified as a strong, intermediate, or weak positive by trained specialists working in the field. In addition, compared to LAT, other more sophisticated tests, including enzyme-linked immunosorbent assays and chemiluminescence immunoassays, give results that are more accurate and rapid.
Covid-19 Impact:
Due to an increase in specific tests (C-reactive protein (CRP) and D-dimer) performed during the COVID-19 pandemic, the pandemic had a favorable effect. As patient visits to healthcare institutions decreased, fewer diagnoses of other diseases, including E. coli, pneumonia, and autoimmune disease, occurred. This had a detrimental influence on the market. Due to supply chain disruptions during the COVID-19 pandemic, the situation for businesses that manufacture latex agglutination test kits was unpredictable. The decrease was seen as a result of a number of factors, including a decrease in the number of autoimmune, E. coli, and pneumonia tests performed, a decrease in overall patient visits to hospitals and diagnoses, a reduction in the ability of hospitals to diagnose diseases other than COVID-19, and others.
The antigen testing segment is expected to be the largest during the forecast period
Due to the enormous number of patients affected by diverse bacterial, viral, and fungal infections, the antigen testing segment held the largest share of the global market for latex agglutination test kits. Antigen testing is recommended for the majority of these infectious disease patients in order to diagnose the illness. In 2020, a study was carried out at the Children's Hospital of Zhejiang University, School of Medicine, according to the Journal of Clinical Laboratory Analysis (Hangzhou, China). It was discovered that this test had favorable outcomes and was effective in detecting rotavirus and adenovirus antigens. This test had a rotavirus detection sensitivity of 81.0% and a specificity of 97.4%.
The blood segment is expected to have the highest CAGR during the forecast period
Because of its widespread use in test kits for antigen and antibody latex agglutination, the blood segment is anticipated to have lucrative expansion throughout the forecast period. Blood or serum samples are required for a number of bacterial and fungal detections. These elements boosted the segment's growth. For instance, a retrospective analysis of patients with cryptococcosis from 2002 to 2019 at Barnes-Jewish Hospital indicated that the sensitivity for serum CrAg latex agglutination was assessed to be 94.7%, according to a report by the National Institutes of Health (NIH) in 2020.
Region with largest share:
Due to the wide range of diseases for which these kits are used, as well as the presence of significant market participants in North America, it is predicted that the region would dominate the global market during the projection period. Moreover, the broad use of these test kits and the rising number of labs with Clinical Laboratory Improvement Amendments (CLIA) certification are anticipated to fuel market expansion in the region.
Region with highest CAGR:
Owing to the region's significant share of the worldwide burden of infectious diseases, Asia-Pacific is predicted to experience the highest CAGR during the forecast period. Moreover, the promotion of latex agglutination testing will be aided by the growth of hospital-based laboratories and independent laboratories. Furthermore, increasing R&D initiatives to evaluate the effectiveness of these kits and rising government spending on patient diagnostic care are other factors driving market expansion in this region.
Key players in the market
Some of the key players in Latex Agglutination Test Kits market include Arlington Scientific, Inc., Atlas Medical GmbH, BioLegend, Bio-Rad Laboratories, Inc., Biotec (Novacyt), Creative Diagnostics, Hardy Diagnostics, HiMedia Laboratories, Liofilchem S.r.l., Pro Lab Diagnostics Inc. and Thermo Fisher Scientific Inc..
Key Developments:
In July 2022, Bio-Rad Laboratories, Inc. launched two products, the Synthetic Negative Run Control for tick-borne, meningitis/encephalitis, and sexually-transmitted infections products, and HAI Negative Run Control for hospital-associated infections products.
In June 2022, Thermo Fisher Scientific partnered with Diagnostic BioSystems (DBS) to offer a wide spectrum of primary antibodies in the U.S.
In April 2022, Bio-Rad Laboratories, Inc. participated in the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022. The company showcased its complete range of infectious disease testing systems, reagents, and quality controls for optimizing testing workflows.
In October 2021, Hardy Diagnostics launched the HardyCHROM Candida + Auris. It is a chromogenic media for the selective isolation and differential identification of Candida species.
In August 2021, Hardy Diagnostics launched the HardyCHROM Group A Strep agar. It is a chromogenic medium for the selective cultivation and differentiation of Group A Streptococcus (S. pyogenes) from clinical specimens.
Test Types Covered:
• Antibody Detection
• Antigen Testing
• Other Test Types
Sample Types Covered:
• Urine
• Blood
• Cerebrospinal Fluid (Lumber Puncture)
• Sperm
• Other Sample Types
Indications Covered:
• Bacterial Meningitis
• C Reactive Protein (CRP)
• Rheumatoid Arthritis (RA)
• Staphylococcus Aureus
• E.coli
• Other Indications
Products Covered:
• Hemagglutination Inhibition
• Indirect Fuorescent Antibody Test
• Serum Neutralization
• Other Products
Applications Covered:
• Research Use
• Diagnostics
• Specialty Clinics
• Other Applications
End Users Covered:
• Standalone Clinical Laboratories
• Hospital-based Laboratories
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Latex Agglutination Test Kits Market, By Test Type
5.1 Introduction
5.2 Antibody Detection
5.3 Antigen Testing
5.3.1 Staphylococcus Aureus
5.3.2 Streptococcus
5.3.3 Escherichia Coli
5.4 Other Test Types
6 Global Latex Agglutination Test Kits Market, By Sample Type
6.1 Introduction
6.2 Urine
6.3 Blood
6.4 Cerebrospinal Fluid (Lumber Puncture)
6.5 Sperm
6.6 Other Sample Types
7 Global Latex Agglutination Test Kits Market, By Indication
7.1 Introduction
7.2 Bacterial Meningitis
7.3 C Reactive Protein (CRP)
7.4 Rheumatoid Arthritis (RA)
7.5 Staphylococcus Aureus
7.6 E.coli
7.7 Other Indications
8 Global Latex Agglutination Test Kits Market, By Product
8.1 Introduction
8.2 Hemagglutination Inhibition
8.3 Indirect Fuorescent Antibody Test
8.4 Serum Neutralization
8.5 Other Products
9 Global Latex Agglutination Test Kits Market, By Application
9.1 Introduction
9.2 Research Use
9.2.1 Academic & Research Institutes
9.3 Diagnostics
9.3.1 Veterinary Use
9.3.2 Human Use
9.4 Specialty Clinics
9.5 Other Applications
10 Global Latex Agglutination Test Kits Market, By End User
10.1 Introduction
10.2 Standalone Clinical Laboratories
10.3 Hospital-based Laboratories
10.4 Other End Users
11 Global Latex Agglutination Test Kits Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Arlington Scientific, Inc.
13.2 Atlas Medical GmbH
13.3 BioLegend
13.4 Bio-Rad Laboratories, Inc.
13.5 Biotec (Novacyt)
13.6 Creative Diagnostics
13.7 Hardy Diagnostics
13.8 HiMedia Laboratories
13.9 Liofilchem S.r.l.
13.10 Pro Lab Diagnostics Inc.
13.11 Thermo Fisher Scientific Inc.
List of Tables
1 Global Latex Agglutination Test Kits Market Outlook, By Region (2020-2028) ($MN)
2 Global Latex Agglutination Test Kits Market Outlook, By Test Type (2020-2028) ($MN)
3 Global Latex Agglutination Test Kits Market Outlook, By Antibody Detection (2020-2028) ($MN)
4 Global Latex Agglutination Test Kits Market Outlook, By Antigen Testing (2020-2028) ($MN)
5 Global Latex Agglutination Test Kits Market Outlook, By Staphylococcus Aureus (2020-2028) ($MN)
6 Global Latex Agglutination Test Kits Market Outlook, By Streptococcus (2020-2028) ($MN)
7 Global Latex Agglutination Test Kits Market Outlook, By Escherichia Coli (2020-2028) ($MN)
8 Global Latex Agglutination Test Kits Market Outlook, By Other Test Types (2020-2028) ($MN)
9 Global Latex Agglutination Test Kits Market Outlook, By Sample Type (2020-2028) ($MN)
10 Global Latex Agglutination Test Kits Market Outlook, By Urine (2020-2028) ($MN)
11 Global Latex Agglutination Test Kits Market Outlook, By Blood (2020-2028) ($MN)
12 Global Latex Agglutination Test Kits Market Outlook, By Cerebrospinal Fluid (Lumber Puncture) (2020-2028) ($MN)
13 Global Latex Agglutination Test Kits Market Outlook, By Sperm (2020-2028) ($MN)
14 Global Latex Agglutination Test Kits Market Outlook, By Other Sample Types (2020-2028) ($MN)
15 Global Latex Agglutination Test Kits Market Outlook, By Indication (2020-2028) ($MN)
16 Global Latex Agglutination Test Kits Market Outlook, By Bacterial Meningitis (2020-2028) ($MN)
17 Global Latex Agglutination Test Kits Market Outlook, By C Reactive Protein (CRP) (2020-2028) ($MN)
18 Global Latex Agglutination Test Kits Market Outlook, By Rheumatoid Arthritis (RA) (2020-2028) ($MN)
19 Global Latex Agglutination Test Kits Market Outlook, By Staphylococcus Aureus (2020-2028) ($MN)
20 Global Latex Agglutination Test Kits Market Outlook, By E.coli (2020-2028) ($MN)
21 Global Latex Agglutination Test Kits Market Outlook, By Other Indications (2020-2028) ($MN)
22 Global Latex Agglutination Test Kits Market Outlook, By Product (2020-2028) ($MN)
23 Global Latex Agglutination Test Kits Market Outlook, By Hemagglutination Inhibition (2020-2028) ($MN)
24 Global Latex Agglutination Test Kits Market Outlook, By Indirect Fuorescent Antibody Test (2020-2028) ($MN)
25 Global Latex Agglutination Test Kits Market Outlook, By Serum Neutralization (2020-2028) ($MN)
26 Global Latex Agglutination Test Kits Market Outlook, By Other Products (2020-2028) ($MN)
27 Global Latex Agglutination Test Kits Market Outlook, By Application (2020-2028) ($MN)
28 Global Latex Agglutination Test Kits Market Outlook, By Research Use (2020-2028) ($MN)
29 Global Latex Agglutination Test Kits Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
30 Global Latex Agglutination Test Kits Market Outlook, By Diagnostics (2020-2028) ($MN)
31 Global Latex Agglutination Test Kits Market Outlook, By Veterinary Use (2020-2028) ($MN)
32 Global Latex Agglutination Test Kits Market Outlook, By Human Use (2020-2028) ($MN)
33 Global Latex Agglutination Test Kits Market Outlook, By Specialty Clinics (2020-2028) ($MN)
34 Global Latex Agglutination Test Kits Market Outlook, By Other Applications (2020-2028) ($MN)
35 Global Latex Agglutination Test Kits Market Outlook, By End User (2020-2028) ($MN)
36 Global Latex Agglutination Test Kits Market Outlook, By Standalone Clinical Laboratories (2020-2028) ($MN)
37 Global Latex Agglutination Test Kits Market Outlook, By Hospital-based Laboratories (2020-2028) ($MN)
38 Global Latex Agglutination Test Kits Market Outlook, By Other End Users (2020-2028) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
